quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:48:21·762d
FDARegulatory
ImmunoGen Inc. logo

FDA Approval for ELAHERE issued to IMMUNOGEN INC

IMGN· ImmunoGen Inc.
Health Care
Original source

Companies

  • IMGN
    ImmunoGen Inc.
    Health Care

Recent analyst ratings

  • Dec 1UpdateGuggenheim$31.00
  • Nov 20UpdateGoldman$17.00
  • Nov 9UpdateDeutsche Bank$25.00
  • Oct 6UpdateOppenheimer$16.00
  • May 3UpdatePiper Sandler$16.00
  • Nov 21UpdateTruist$10.00

Related

  • PR456d
    Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research
  • PR534d
    PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
  • PR534d
    Seaport Therapeutics Names Lauren White as Chief Financial Officer
  • FDA758d
    March 26, 2024 - FDA Roundup: March 26, 2024
  • SEC791d
    SEC Form 15-12G filed by ImmunoGen Inc.
  • 13D/G799d
    SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)
  • 13D/G799d
    SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)
  • 13D/G800d
    SEC Form SC 13G/A filed by ImmunoGen Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022